During the past decade, Ammerland Klinik GmbH conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ammerland Klinik GmbH" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials, followed by "Lombard Medical" with 1 trials sponsored, "Martin-Luther-Universität Halle-Wittenberg" with 1 trials sponsored, "PregLem SA" with 1 trials sponsored and "University Hospital Inselspital, Berne" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ammerland Klinik GmbH" #1 collaborator was "Alfried-Krupp Krankenhaus of Essen, Germany" with 1 trials as a collaborator, "Ammerland Klinik GmbH, Westerstede, Germany" with 1 trials as a collaborator, "Arcispedale Santa Maria Nuova-IRCCS" with 1 trials as a collaborator, "Baystate Medical Center" with 1 trials as a collaborator and "Cantonal Hospital of Aarau, Switzerland" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Ammerland Klinik GmbH" are "Abdominal Aortic Aneurysms" (1 trials), "Brain Ischemia With Non-valvular Atrial Fibrillation" (1 trials), "Lymphoma" (1 trials), "Metastatic Colorectal Cancer" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Ammerland Klinik GmbH" in a lesser frequency.

Most popular intervention types in "Ammerland Klinik GmbH" are "Drug" (3 trials), "Device" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "5FU/LV, Oxaliplatin, Bevacizumab, Irinotecan" (1 trials), "Antithrombotic treatment" (1 trials), "Oxaliplatin, 5FU/LV, Bevacizumab" (1 trials), "Stent Graft" (1 trials) and "cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ammerland Klinik GmbH" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ammerland Klinik GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ammerland Klinik GmbH, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ammerland Klinik GmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".